Omada Health (NASDAQ:OMDA) CFO Sells $40,191.07 in Stock

Omada Health, Inc. (NASDAQ:OMDA) CFO Steven Cook sold 1,607 shares of the business’s stock in a transaction that occurred on Tuesday, August 11th. The stock was sold at an average price of $25.01, for a total transaction of $40,191.07. Following the sale, the chief financial officer owned 187,209 shares of the company’s stock, valued at approximately $4,682,097.09. This represents a 0.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Omada Health Trading Down 1.4%

Shares of OMDA stock opened at $24.04 on Friday. The company’s fifty day simple moving average is $20.99 and its 200-day simple moving average is $16.49. Omada Health, Inc. has a 52 week low of $10.28 and a 52 week high of $26.92. The company has a market cap of $1.47 billion, a PE ratio of 480.80 and a beta of 1.73.

Omada Health (NASDAQ:OMDA) last posted its earnings results on Thursday, August 6th. The company reported $0.08 earnings per share for the quarter, beating the consensus estimate of ($0.02) by $0.10. Omada Health had a net margin of 1.39% and a return on equity of 2.60%. The business had revenue of $87.83 million for the quarter, compared to analyst estimates of $80.93 million. Equities research analysts expect that Omada Health, Inc. will post -0.01 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research analysts have commented on the company. Canaccord Genuity Group boosted their price objective on Omada Health from $24.00 to $28.00 and gave the stock a “buy” rating in a research note on Tuesday, July 21st. Morgan Stanley reiterated an “overweight” rating and issued a $30.00 target price on shares of Omada Health in a research note on Monday, June 22nd. Wall Street Zen upgraded Omada Health from a “hold” rating to a “buy” rating in a report on Saturday, August 8th. Weiss Ratings raised Omada Health from a “sell (e+)” rating to a “sell (d+)” rating in a research report on Tuesday. Finally, BMO Capital Markets restated an “outperform” rating and issued a $24.00 price target on shares of Omada Health in a report on Friday, August 7th. Eleven investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $26.50.

Hedge Funds Weigh In On Omada Health

Institutional investors have recently added to or reduced their stakes in the company. Raymond James Financial Inc. purchased a new position in Omada Health in the 2nd quarter valued at about $32,000. Quarry LP purchased a new stake in shares of Omada Health during the fourth quarter worth about $29,000. TD Waterhouse Canada Inc. purchased a new stake in shares of Omada Health during the fourth quarter worth about $32,000. Inlight Wealth Management LLC acquired a new position in shares of Omada Health in the fourth quarter worth about $45,000. Finally, Versant Capital Management Inc lifted its stake in shares of Omada Health by 319.3% in the second quarter. Versant Capital Management Inc now owns 2,998 shares of the company’s stock worth $66,000 after acquiring an additional 2,283 shares in the last quarter.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.